Lyric Bio
CA - San FranciscoBiotechnology
Focus: Lyric Bio is a public biotechnology company focused on therapeutics manufacturing technology and bioreactor innovation, primarily serving the oncology space.
Profile data last refreshed 3h ago · AI intelligence enriched 1mo ago
Funding Stage
PUBLIC
Open Jobs
25+25 this month
Hot — 29 jobs added in 30d
Net +25 (29 new, 4 removed). Aggressive expansion phase.
Should You Work at Lyric Bio?
AI assessmentLyric Bio may appeal to candidates seeking manufacturing/platform technology expertise in biotech, but the lack of hiring activity and sparse pipeline data warrant deep due diligence before pursuing opportunities.
Why Work Here
- Public company status provides equity upside potential and established governance structures
- Specialized focus on manufacturing technology and bioreactors positions the company in a high-growth enabling segment
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Lyric Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.